Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Videos
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Shop
  • Events
  • Contact us

Andrew’s story

Andrew's story

I was first diagnosed with prostate cancer in October 2013 and it has been an emotional roller-coaster ride since. 

My GP decided to start 6-monthly PSA test for me in my mid-50’s, I’m 61 now. My PSA was 2.61 in 2009, and steadily increased to 6.2 by 2013, at which point my GP suggested I see a Urologist, who was Mark Emberton.

My first rectal (finger) examination and ultrasound check did not reveal any evidence of prostate cancer. However, Magnetic Resonance Imaging (MRI) then Trans Perineal Mapping (TPM) (not TRUS) biopsy showed that I had an anterior index lesion (tumour) in my prostate right side, with a “score” of 12mm of Gleason 3+4 pattern 4 accounting for 30% of tumour load. (“Anterior” means the side of my prostate furthest from my posterior, or back passage.)

This caused mixed reactions from me: even though I always believe that whatever happens to me is God’s will, I still tended to have the emotions of anger and distress.

To summarise what the above “scientific” stuff means: I have a low-risk index (main) tumour, but, according to my estimation, it could certainly cause problems and noticeable symptoms if left for more than 5 years. So my decision: have it zapped now!

Interestingly, Mark Emberton said it would have been even better had I gone to him even earlier in 2012, when my PSA was around 4.

After several consultations with the excellent team at UCLH, and much prayer, I’ve decided to have Cryotherapy to destroy my index (main) lesion (tumour).

Unfortunately, I did not qualify for the Nano Knife trial, since I also have 5mm of Gleason 3 on my right lateral aspect (on my prostate posterior, back passage, side). This latter I’ve decided to leave for surveillance – to me, it appears to be much lower risk.

Perhaps one of the most traumatic times so far in all this, was when I went for my initial appointment for cryotherapy. Being last in that days theatre list, and having been I.D. tagged, had consultation with anaesthetic and surgical team members (as is usual), and waited an fasted for several hours in surgical reception, I was told, gently, that because a previous (and probably less fortunate) patient had complications and his surgery was taking longer than was expected, my cryo surgery was cancelled for that day.

My initial distress gave way to understanding, as I realised, firstly, that one of the theatre team (Manit’s consultant) had made a special effort to come from theatre to tell me himself, and that every patient’s BEST treatment in theatre MUST be the first priority. Reassuring to realise that they won’t kick me off the table regardless, when the theoretical 2 hours’ procedure time is up!

Since September 2013, I must have studied prostate cancer with more intensity than all my student years put together! It’s made me start asking the sorts of questions that many a urologist probably asks.

So, for anyone else who’s been diagnosed with early stage prostate cancer: don’t automatically opt for total removal or destruction of your prostate! The focal or index therapies appear to offer a good cure, with only minimal chances of side-effects, except for one: the only down-side to my treatment (and all prostate treatments) appears to be the permanent side-effect of a “dry climax”. The probability of this is 50%. (All these figures are from the UCLH patient information sheets and discussions with Emberton and his team.) However, as with ALL medical treatments, the desirable benefits need to be considered in balance with the undesirable side-effects.

And now for something completely different: Suggestions please: since I have a family history of bowel cancer, does anyone know of a way of monitoring for early stages of it, other than colonoscopy (which I’ve had and will have again)? An equivalent blood test just like PSA for prostate would be ideal! (Ed: you can have a faecal occult blood test to see if there is any blood in your poo or a blood test to check for anaemia (a low number of red blood cells), which is common in people with bowel cancer)

Pelican Cancer Foundation Follow

Driving innovation and advancing surgery to help patients live well, for longer.

Pelican_Cancer
sam_meso Sam Westbrook @sam_meso ·
22 Jun

What an amazing peritoneal malignancy event. Patients and their families joined us for a wellbeing day which included fabulous talks from the whole team. Thank you to @Team_Hasag and all those supporting the day @BasingstokePmi @meso_sheffield @FaheezM @Mesouk @Pelican_Cancer

Reply on Twitter 1539708098658566145 Retweet on Twitter 1539708098658566145 17 Like on Twitter 1539708098658566145 59 Twitter 1539708098658566145
sharkscubadave David Holmes @sharkscubadave ·
16 Jun

Two weeks ago today, I started on the journey North to complete the #threepeakschallenge with my team from @RedcoLtd and @rdmlsigns. We completed the challenge and we are still raising funds for @Pelican_Cancer

http://www.justgiving.com/fundraising/peaksforpelican

Video here at: https://youtu.be/4pd_iidx2Jc

Reply on Twitter 1537408209752936450 Retweet on Twitter 1537408209752936450 1 Like on Twitter 1537408209752936450 3 Twitter 1537408209752936450
faheezm Faheez Mohamed @faheezm ·
22 Jun

Marcus Remer discussing Immunotherapy for peritoneal mesothelioma at @BasingstokePmi patient well-being day @CancercareHhft @HJrespiratory @HelenChilds_rwk @Mesouk @sam_meso @Team_Hasag

Reply on Twitter 1539579616402313216 Retweet on Twitter 1539579616402313216 11 Like on Twitter 1539579616402313216 40 Twitter 1539579616402313216
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2022 · Outreach Pro Theme on Genesis Framework · WordPress · Log in